DrugJul 29, 2026
Rohto Cooling Eye Drops ALL-IN-ONE recall — FDA D-0715-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
July 2026 recalls — page 3
These records include useful source details for the selected month.
DrugJul 29, 2026
Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10) recall — FDA D-0735-2026
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12…
Class IIIFDA: OngoingAscend Laboratories, LLC
DrugJul 29, 2026
Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle recall — FDA D-0732-2026
Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be…
Class IFDA: OngoingJB Chemicals and Pharmaceuticals Ltd
DrugJul 29, 2026
CYPROHEPTADINE HYDROCHLORIDE Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL recall — FDA D-0724-2026
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Class IIFDA: OngoingRising Pharma Holding, Inc.
DrugJul 29, 2026
Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 10 Tablets (10 x 1) unit dose blisters recall — FDA D-0708-2026
Subpotent Drug
Class IIFDA: OngoingMajor Pharmaceuticals
DrugJul 29, 2026
Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL recall — FDA D-0725-2026
Presence of Particulate Matter: Hair was found in product
Class IIFDA: OngoingFresenius Kabi USA, LLC
DrugJul 29, 2026
Xylocaine recall — FDA D-0729-2026
Presence of Particulate Matter: Hair was found in products
Class IIFDA: OngoingFresenius Kabi USA, LLC
DrugJul 29, 2026
Rohto Cooling Eye Drops Optic Glow recall — FDA D-0718-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
DrugJul 29, 2026
Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets (10 x 1) unit dose blisters recall — FDA D-0707-2026
Subpotent Drug
Class IIFDA: OngoingMajor Pharmaceuticals
DrugJul 29, 2026
Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle recall — FDA D-0712-2026
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
Class IIFDA: OngoingAscend Laboratories, LLC
DrugJul 29, 2026
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use recall — FDA D-0713-2026
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Class IIIFDA: OngoingAsclemed USA Inc.
DrugJul 29, 2026
Rohto Cooling Eye Drops Max Strength recall — FDA D-0717-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
DrugJul 29, 2026
Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL recall — FDA D-0726-2026
Presence of Particulate Matter: Hair was found in products
Class IIFDA: OngoingFresenius Kabi USA, LLC
DrugJul 29, 2026
Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10) recall — FDA D-0736-2026
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12…
Class IIIFDA: OngoingAscend Laboratories, LLC
DrugJul 29, 2026
Rohto Cooling Eye Drops Dry Aid recall — FDA D-0720-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
DrugJul 29, 2026
Xylocaine recall — FDA D-0728-2026
Presence of Particulate Matter: Hair was found in products
Class IIFDA: OngoingFresenius Kabi USA, LLC
DrugJul 29, 2026
Rohto Cooling Eye Drops Digi Eye recall — FDA D-0719-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
DrugJul 29, 2026
Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose recall — FDA D-0710-2026
Subpotent Drug
Class IIFDA: OngoingMajor Pharmaceuticals
DrugJul 29, 2026
Naropin recall — FDA D-0727-2026
Presence of Particulate Matter: Hair was found in products
Class IIFDA: OngoingFresenius Kabi USA, LLC
DrugJul 29, 2026
Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose recall — FDA D-0711-2026
Subpotent Drug
Class IIFDA: OngoingMajor Pharmaceuticals
DrugJul 29, 2026
Rohto Cooling Eye Drops Cool Relief recall — FDA D-0722-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
DrugJul 29, 2026
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters recall — FDA D-0709-2026
Subpotent Drug
Class IIFDA: OngoingMajor Pharmaceuticals
DrugJul 29, 2026
Rohto Cooling Eye Drops Max Strength recall — FDA D-0716-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingRohto-Mentholatum (Vietnam) Co., Ltd.
FoodJul 29, 2026
GELLERT GLOBAL GROUP Fusia, Asian Inspirations, Kimchi & Tofu Kimbap, 8.1 OZ recall — FDA H-1186-2026
Undeclared Allergen (Fish)
Class IFDA: OngoingGELLERT GLOBAL GROUP
How to use this monthly recall archive
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.